Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
RBD-specific polyclonal F(ab´)2 fragments of equine antibodies in patients with moderate to severe COVID-19 disease: A randomized, multicenter, double-blind, placebo-controlled, adaptive phase 2/3 clinical trial.
EClinicalMedicine. 2021 Apr;34:100843. doi: 10.1016/j.eclinm.2021.100843. Epub 2021 Apr 11.
EClinicalMedicine. 2021.
PMID: 33870149
Free PMC article.
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial.
Marconi VC, Ramanan AV, de Bono S, Kartman CE, Krishnan V, Liao R, Piruzeli MLB, Goldman JD, Alatorre-Alexander J, de Cassia Pellegrini R, Estrada V, Som M, Cardoso A, Chakladar S, Crowe B, Reis P, Zhang X, Adams DH, Ely EW; COV-BARRIER Study Group.
Marconi VC, et al.
Lancet Respir Med. 2021 Dec;9(12):1407-1418. doi: 10.1016/S2213-2600(21)00331-3. Epub 2021 Sep 1.
Lancet Respir Med. 2021.
PMID: 34480861
Free PMC article.
Clinical Trial.
Item in Clipboard
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial.
Lescure FX, Honda H, Fowler RA, Lazar JS, Shi G, Wung P, Patel N, Hagino O; Sarilumab COVID-19 Global Study Group.
Lescure FX, et al.
Lancet Respir Med. 2021 May;9(5):522-532. doi: 10.1016/S2213-2600(21)00099-0. Epub 2021 Mar 4.
Lancet Respir Med. 2021.
PMID: 33676590
Free PMC article.
Clinical Trial.
Item in Clipboard
[Degree of satisfaction with the informed consent process and participation in clinical trials. A 3400 patients' study].
Ibelli FB, Scublinsky D, Acuña E, Higuera F, Vidal E, Iannantuono R.
Ibelli FB, et al. Among authors: scublinsky d.
Medicina (B Aires). 2022;82(4):534-543.
Medicina (B Aires). 2022.
PMID: 35904908
Free article.
Spanish.
Item in Clipboard
[Cardiovascular safety of hydroxychloroquine in the COVID-19 pandemic].
Bozzo R, Ibelli F, Scublinsky D.
Bozzo R, et al. Among authors: scublinsky d.
Medicina (B Aires). 2020;80 Suppl 3:89-90.
Medicina (B Aires). 2020.
PMID: 32658855
Free article.
Spanish.
No abstract available.
Item in Clipboard
The prevalence of rheumatoid arthritis in Argentina: a capture-recapture study in a city of Buenos Aires province.
Scublinsky D, Venarotti H, Citera G, Messina OD, Scheines E, Rillo O, Arturi A, Hofman J, Somma LF, Casado G, Iannantuono RF, Gonzalez CD.
Scublinsky D, et al.
J Clin Rheumatol. 2010 Oct;16(7):317-21. doi: 10.1097/RHU.0b013e3181f3bfdd.
J Clin Rheumatol. 2010.
PMID: 20859227
Item in Clipboard
Quantifying Disease in Challenging Conditions: Incidence and Prevalence of Rheumatoid Arthritis.
Scublinsky D, Gonzalez CD.
Scublinsky D, et al.
J Rheumatol. 2016 Jul;43(7):1263-4. doi: 10.3899/jrheum.160522.
J Rheumatol. 2016.
PMID: 27371645
No abstract available.
Item in Clipboard
Cite
Cite